Analysts Showing Optimistic Trends For Abbott Laboratories (ABT)

0
13

Abbott Laboratories (ABT) will report its next earnings on Apr 18 – Apr 24 (Est.). The company reported the earnings of $0.65/Share in the last quarter where the estimated EPS by analysts was $0.65/share. The difference between the expected and actual EPS was $0/share, which represents an Earnings surprise of 0%.

Many analysts are providing their Estimated Earnings analysis for Abbott Laboratories and for the current quarter 14 analysts have projected that the stock could give an Average Earnings estimate of $0.43/share. These analysts have also projected a Low Estimate of $0.43/share and a High Estimate of $0.43/share.

In case of Revenue Estimates, 13 analysts have provided their consensus Average Revenue Estimates for Abbott Laboratories as 6.16 Billion. According to these analysts, the Low Revenue Estimate for Abbott Laboratories is 6.01 Billion and the High Revenue Estimate is 6.36 Billion. The company had Year Ago Sales of 4.88 Billion.

These analysts also forecasted Growth Estimates for the Current Quarter for ABT to be 4.9%. They are projecting Next Quarter growth of 9.1%. For the next 5 years, Abbott Laboratories is expecting Growth of 11.24% per annum, whereas in the past 5 years the growth was -14.79% per annum.

Some buy side analysts are also providing their Analysis on Abbott Laboratories, where 0 analysts have rated the stock as Strong buy, 0 analysts have given a Buy signal, 0 said it’s a HOLD, 0 reported it as Underperform and 0 analysts rated the stock as Sell. (These Recommendations are for the Current Month Only reported by Yahoo Finance.)

When it comes to the Analysis of a Stock, Price Target plays a vital role. 13 Analysts reported that the Price Target for Abbott Laboratories might touch $52 high while the Average Price Target and Low price Target is $47.85 and $41 respectively.

To analyze a stock, one should look for Upgrades and Downgrades of a stock. Abbott Laboratories got Upgrade on 21-Jun-16 where investment firm Edward Jones Upgrade the stock from Hold to Buy.

Abbott Laboratories closed its last trading session at $44.98 with the gain of 0.47%. The Market Capitalization of the company stands at 77.93 Billion. The Company has 52-week high of $45.84 and 52-week low of $36.76. The stock’s current distance from 20-Day Simple Moving Average (SMA20) is -0.08% where SMA50 and SMA200 are 5.2% and 10.2% respectively. The Company Touched its 52-Week High on Mar 10, 2017 and 52-Week Low on Jun 27, 2016.

The Relative Volume of the company is 1.39 and Average Volume (3 months) is 8.82 million. Abbott Laboratories P/E (price to earnings) ratio is 63.11 and Forward P/E ratio of 16.43.

The company shows its Return on Assets (ROA) value of 3.3%. The Return on Equity (ROE) value stands at 6.8%. While it’s Return on Investment (ROI) value is 6.7%.

While looking at the Stock’s Performance, Abbott Laboratories currently shows a Weekly Performance of -1.16%, where Monthly Performance is 2.7%, Quarterly performance is 17.16%, 6 Months performance is 11.31% and yearly performance percentage is 15%. Year to Date performance value (YTD perf) value is 18.41%. The Stock currently has a Weekly Volatility of 1.26% and Monthly Volatility of 1.13%.